| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 238.71B | 236.33B | 223.20B | 212.36B | 208.08B | 200.68B |
| Gross Profit | 93.91B | 92.89B | 87.31B | 84.44B | 86.03B | 83.01B |
| EBITDA | 22.14B | 22.01B | 20.13B | 20.16B | 25.27B | 25.36B |
| Net Income | 11.34B | 11.22B | 9.82B | 10.25B | 14.30B | 14.73B |
Balance Sheet | ||||||
| Total Assets | 138.49B | 142.95B | 133.77B | 127.94B | 122.70B | 115.39B |
| Cash, Cash Equivalents and Short-Term Investments | 58.80B | 62.15B | 58.19B | 58.08B | 58.25B | 53.59B |
| Total Debt | 1.28B | 1.43B | 1.78B | 1.90B | 1.98B | 2.08B |
| Total Liabilities | 30.32B | 34.94B | 31.73B | 30.49B | 30.24B | 30.18B |
| Stockholders Equity | 108.17B | 108.00B | 102.04B | 97.45B | 92.46B | 85.21B |
Cash Flow | ||||||
| Free Cash Flow | 3.27B | 10.93B | 7.08B | 6.74B | 13.41B | 14.79B |
| Operating Cash Flow | 4.60B | 16.00B | 12.23B | 11.34B | 17.65B | 19.45B |
| Investing Cash Flow | -4.73B | -12.28B | -6.19B | -6.61B | -2.34B | -7.92B |
| Financing Cash Flow | -1.48B | -5.92B | -5.94B | -5.95B | -7.74B | -5.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥115.99B | 16.52 | ― | 1.92% | 2.30% | 26.52% | |
74 Outperform | ¥287.42B | 11.04 | 12.03% | 1.96% | 4.24% | 13.79% | |
72 Outperform | ¥224.95B | 15.19 | ― | 2.43% | 4.48% | 13.17% | |
68 Neutral | ¥3.08T | 19.75 | 16.37% | 0.73% | 6.23% | 16.45% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥24.89B | 14.80 | ― | 2.89% | 6.70% | 7.79% | |
42 Neutral | ¥53.32B | -875.07 | ― | 0.51% | 2.90% | ― |